Generation of Human Induced Pluripotent Stem Cell Line from a Patient with Restrictive Cardiomyopathy

Jingxian Li,Jinxiu Jiang,Lingqun Ye,Zhipeng Lian,Hui Gong,Wei Lei,Yuxiang Dai,Shijun Hu
DOI: https://doi.org/10.1016/j.scr.2024.103370
IF: 1.587
2024-01-01
Stem Cell Research
Abstract:Restrictive cardiomyopathy (RCM) is a rare cardiomyopathy characterized by diastolic dysfunction, which affects cardiac systolic function. We successfully established human induced pluripotent stem cells (hiPSCs) from peripheral blood mononuclear cells of 24-year-old male with restrictive cardiomyopathy (RCM). The patient-derived hiPSCs carried heterozygous mutation of CRYAB gene (c.326A > G, p.D109G), which was consistent with clinical whole exon sequencing results. We confirmed the pluripotency, multipotential differentiation and karyotype of hiPSCs. The hiPSCs will be useful for studying the pathogenesis of RCM caused by CRYAB (c.326A > G) mutation.
What problem does this paper attempt to address?